We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+0.1%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$68.4B
AUM Growth
-$6.42B
(-8.6%)
Cap. Flow
-$9.95B
Cap. Flow
% of AUM
-14.55%
Top 10 Holdings %
Top 10 Hldgs %
25.74%
Holding
2,605
New
281
Increased
825
Reduced
894
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$433M |
| 2 |
Merck
MRK
|
+$286M |
| 3 |
Jacobs Solutions
J
|
+$265M |
| 4 |
Equifax
EFX
|
+$253M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$710M |
| 2 |
Johnson & Johnson
JNJ
|
+$574M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$480M |
| 4 |
Marvell Technology
MRVL
|
+$377M |
| 5 |
Wells Fargo
WFC
|
+$333M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.04% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 12% |
| 4 | Industrials | 10.54% |
| 5 | Consumer Discretionary | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
StealthGas
GASS
$318M
| $61K | ﹤0.01% |
+10,917
| New | +$63.9K |
|
1752
Kiniksa Pharmaceuticals
KNSA
$6.09B
| $61K | ﹤0.01% |
+3,098
| New | +$70.7K |
|
1753
MiMedx Group
MDXG
$606M
| $61K | ﹤0.01% |
6,405
-27,390
| -81% | -$213K |
|
1754
Amphastar Pharmaceuticals
AMPH
$877M
| $60K | ﹤0.01% |
1,630
-5,771
| -78% | -$264K |
|
1755
ONE Gas
OGS
$4.97B
| $60K | ﹤0.01% |
881
-53
| -6% | -$3.87K |
|
|
STKL
1756
DELISTED
SunOpta
STKL
| $60K | ﹤0.01% |
7,814
-577
| -7% | -$4.08K |
|
|
CIVI
1757
DELISTED
Civitas Resources
CIVI
| $59K | ﹤0.01% |
1,288
-3,727
| -74% | -$186K |
|
|
GDEN
1758
DELISTED
Golden Entertainment
GDEN
| $59K | ﹤0.01% |
1,871
+1,501
| +406% | +$47.6K |
|
1759
International Bancshares
IBOC
$4.72B
| $59K | ﹤0.01% |
944
-68
| -7% | -$4.51K |
|
|
AD
1760
Array Digital Infrastructure
AD
$3.06B
| $58K | ﹤0.01% |
930
+882
| +1,838% | +$53.9K |
|
1761
Byrna Technologies
BYRN
$106M
| $57K | ﹤0.01% |
1,990
-161
| -7% | -$3.16K |
|
1762
Elbit Systems
ESLT
$40.5B
| $57K | ﹤0.01% |
222
-15
| -6% | -$3.52K |
|
1763
Indivior Pharmaceuticals
INDV
$4.57B
| $57K | ﹤0.01% |
+4,661
| New | +$47.9K |
|
1764
Planet Fitness
PLNT
$4.48B
| $57K | ﹤0.01% |
+577
| New | +$52.7K |
|
|
CLDT
1765
Chatham Lodging
CLDT
$623M
| $56K | ﹤0.01% |
+6,335
| New | +$56.1K |
|
|
HBI
1766
DELISTED
Hanesbrands
HBI
| $56K | ﹤0.01% |
+6,946
| New | +$54.7K |
|
|
B
1767
DELISTED
Barnes Group Inc.
B
| $55K | ﹤0.01% |
+1,168
| New | +$54.3K |
|
1768
Digital Turbine
APPS
$1.59B
| $54K | ﹤0.01% |
+32,149
| New | +$71.5K |
|
1769
Huntington Bancshares
HBAN
$35.6B
| $54K | ﹤0.01% |
3,347
| – | – |
|
1770
Seneca Foods Class A
SENEA
$1.16B
| $54K | ﹤0.01% |
+692
| New | +$47.6K |
|
1771
American Financial Group
AFG
$12.2B
| $53K | ﹤0.01% |
+391
| New | +$53.8K |
|
1772
Peabody Energy
BTU
$2.78B
| $53K | ﹤0.01% |
2,546
-161
| -6% | -$3.98K |
|
1773
Inseego
INSG
$121M
| $53K | ﹤0.01% |
5,244
+5,067
| +2,863% | +$74.4K |
|
1774
Upbound Group
UPBD
$1.17B
| $53K | ﹤0.01% |
1,890
-418
| -18% | -$13K |
|
1775
BK Technologies
BKTI
$292M
| $52K | ﹤0.01% |
1,544
+1,494
| +2,988% | +$45.6K |
|
Similar funds
QCM
Lazard Asset Management's Q4 2024 Portfolio in Review
As of Q4 2024, Lazard Asset Management held 2,605 positions worth $68.4B, down 8.6% from $74.8B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Lazard Asset Management withdrew a net $9.95B in Q4 2024, closing 234 positions and reducing 894 holdings. Its most notable exit was Atlantica Sustainable Infrastructure plc Ordinary Shares, an estimated $210M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Lazard Asset Management opened a new position in Vaxcyte worth $39.8M.
- Lazard Asset Management's largest Q4 2024 buy was Vaxcyte: 486,764 shares worth $39.8M.
- Lazard Asset Management added most to Eli Lilly in Q4 2024, an estimated $433M increase.
- Lazard Asset Management's biggest Q4 2024 reduction was Microsoft, cutting an estimated $710M.
- Lazard Asset Management fully exited Atlantica Sustainable Infrastructure plc Ordinary Shares in Q4 2024, selling an estimated $210M.
- Lazard Asset Management's ten largest holdings make up 26% of its $68.4B portfolio in Q4 2024.
- Lazard Asset Management opened 281 new positions and closed 234 in Q4 2024.
- Lazard Asset Management's portfolio value fell 8.6% quarter-over-quarter to $68.4B.
Based on Lazard Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.